Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall E Morris

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2018
The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statementMark D Stegall, Kenneth Troy Somerville, Matthew J Everly, et al.
The Journal of Clinical Investigation|August 9, 2008
The PKC inhibitor AEB071 may be a therapeutic option for psoriasisHans Skvara, Markus Dawid, Elise Kleyn, et al.
Transplantation|April 9, 2005
Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primatesDominic C Borie, Paul S Changelian, Michael J Larson, et al.
Transplantation|January 3, 2020
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working GroupCarrie A Schinstock, Roslyn B Mannon, Klemens Budde, et al.
Transplantation|February 17, 2017
Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in DirectionPhilip J OʼConnell, Dirk R Kuypers, Roslyn B Mannon, et al.
Science (New York, N.Y.)|November 1, 2003
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitorPaul S Changelian, Mark E Flanagan, Douglas J Ball, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2018
The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statementMark D Stegall, Kenneth Troy Somerville, Matthew J Everly, et al.
The Journal of Clinical Investigation|August 9, 2008
The PKC inhibitor AEB071 may be a therapeutic option for psoriasisHans Skvara, Markus Dawid, Elise Kleyn, et al.
Transplantation|April 9, 2005
Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primatesDominic C Borie, Paul S Changelian, Michael J Larson, et al.
Transplantation|January 3, 2020
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working GroupCarrie A Schinstock, Roslyn B Mannon, Klemens Budde, et al.
Transplantation|February 17, 2017
Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in DirectionPhilip J OʼConnell, Dirk R Kuypers, Roslyn B Mannon, et al.
Science (New York, N.Y.)|November 1, 2003
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitorPaul S Changelian, Mark E Flanagan, Douglas J Ball, et al.
Pageof 5